MedPath

The effect of vitamin D supplementation on uterine myoma

Phase 3
Conditions
terine myoma.
Leiomyoma of uterus, unspecified D25.9
D25.9
Registration Number
IRCT20180610040046N1
Lead Sponsor
Bandare-abbas University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients who are willing to participate and consent to participate in the study
Having 1-3 uterine myoma with at least 10 millimeters diameter in largest myoma according to ultrasound findings
Serum level of vitamin D less than 30ng / ml

Exclusion Criteria

Consuming hormone
Severe vaginal bleeding
Planning for pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of uterine myoma. Timepoint: Before intervention and 4 months after intervention. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
Serum vitamin D levels. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Radioimmunoassay.
© Copyright 2025. All Rights Reserved by MedPath